A Chronic Disease Management Solution

描述(由申请人提供)：Koronis Biomedical Technologies Corporation(KBT)建议开发一种慢性病管理解决方案。根据美国国立卫生研究院的数据，2005年慢性病将占美国医疗费用的75%。拟议的解决方案将服务于患有四种慢性病中一种或多种的大量患者：糖尿病、充血性心力衰竭、慢性阻塞性肺疾病或哮喘。这些疾病占慢性病患者的80%。KBT提议与一家领先的医疗保健技术公司建立合作关系，在自我监测慢性病的患者和护理他们的健康专业人员之间提供现代、互动的协作。拟议的项目将把开发的技术整合到商业上可用的疾病管理平台中，以创建一种具有很高商业成功可能性的新的慢性病管理解决方案。

DESCRIPTION (provided by applicant): Koronis Biomedical Technologies Corporation (KBT) proposes the development of a chronic disease management solution. According to the NIH, chronic diseases in 2005 will account for 75% of U.S. healthcare costs. The proposed solution will serve the large population of patients suffering from one or more of four chronic illnesses: diabetes, congestive heart failure, chronic obstructive pulmonary disease, or asthma. These diseases represent 80% of the patients with chronic disease. KBT proposes a teaming relationship with a pioneering healthcare technology company in the business of providing a modern, interactive collaboration between those patients who are self-monitoring a chronic condition and the health professionals that care for them. The proposed project will integrate the developed technology into a commercially available disease management platform to create a new chronic disease management solution that has a high probability of commercial success.